Aurinia Pharmaceuticals (AUPH) Return on Invested Capital (2023 - 2026)

Aurinia Pharmaceuticals' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Invested Capital rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.04%, up 4.0% from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Aurinia Pharmaceuticals, up from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q1 2026 and bottomed at 0.01% in Q3 2023.
• A 4-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 1 bps in 2024, while the deepest fall reached 0 bps in 2024.
• Aurinia Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2023, then surged by 97 bps to 0.0% in 2024, then soared by 8156 bps to 0.01% in 2025, then rose by 7 bps to 0.01% in 2026.
• Business Quant data shows AUPH's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.